Last update:

Coronavirus (COVID-19)

Medications

Oral nucleoside antiviral is progressing toward future pandemic preparedness

Obeldesivir (GS-5245), a novel investigational small molecule oral antiviral, represents a new tool in the ongoing effort to prepare for future pandemics.

Diseases, Conditions, Syndromes

Immune response study explains why some people don't get COVID-19

Scientists have discovered novel immune responses that help explain how some individuals avoid getting COVID-19.

COVID-19 outbreak

Coronavirus disease 2019 (COVID-19) is the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

A pneumonia of unknown cause detected in Wuhan, China was first reported to the World Health Organization Country Office in China on 31 December 2019 and recognised as a pandemic on 11 March 2020.

Reported illnesses have ranged from mild symptoms to severe illness and death for confirmed COVID-19 cases.

More information: WHO, CDC, global cases.

Follow us on Google News for the latest updates on the coronavirus.

Diseases, Conditions, Syndromes

Study: In severe COVID-19 cases, neutrophils work around the clock

The course of SARS-CoV-2 coronavirus infections depends not only on how aggressive the virus is, but also on the immune response of the infected individual. Using single-cell analyses, a group of researchers led by Samantha ...

Immunology

How COVID-19 'breakthrough' infections alter your immune cells

New research from scientists at La Jolla Institute for Immunology (LJI) suggests people who received COVID-19 vaccines and then experienced "breakthrough" infections are especially well armed against future SARS-CoV-2 infections.